Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-003002
Filing Date
2025-08-20
Accepted
2025-08-20 14:18:25
Documents
3
Period of Report
2025-08-20

Document Format Files

Seq Description Document Type Size
1 6-K zk2533688.htm 6-K 11190
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 13322
3 image00001.jpg GRAPHIC 94417
  Complete submission text file 0001178913-25-003002.txt   155836
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND Ireland
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND Ireland 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-22320 | Film No.: 251236017
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)